Open Accessibility Menu

Monoclonal Antibodies for COVID-19

Available at COVID-19 Infusion Center

Baxter Regional can provide monoclonal antibodies for treatment of COVID-19 for patients who meet certain criteria. For more information, call the Baxter Regional COVID-19 Infusion Center at (870) 508-3010.

In November, 2020, the U.S. Food and Drug Administration issued an Emergency Use Authorization to allow the use of monoclonal antibodies for the treatment of mild to moderate symptoms of COVID-19 in adults and pediatric patients.

Monoclonal antibodies are laboratory-made proteins that mimic your immune system’s ability to fight off harmful viruses. Casirivimab and Imdevimab are monoclonal antibodies that are specifically designed to protect against the spike protein of COVID-19. These proteins are designed to stop the virus from entering the human cells.

Who Can Get This Treatment?

This monoclonal antibodies treatment is for non-hospitalized COVID-19 patients with mild to moderate symptoms with less than 10 days since symptom onset in one of the following high-risk categories.

Age 12 to 17 AND have any of the following:

  • High BMI
  • Sickle cell disease
  • Heart disease
  • Neurodevelopment disorders
  • A medical related dependence
  • Chronic respiratory diseases
  • Asthma

Age 55 to 64 AND have any of the following:

  • Cardiovascular disease
  • Hypertension
  • Chronic respiratory diseases
  • COPD

Age 12 or older AND have any of the following:

  • Chronic Kidney Disease
  • BMI of 35 or Greater
  • Diabetes
  • Immunosuppressive Disease

These medications are NOT approved for use in patients who are hospitalized due to COVID-19 or require oxygen therapy. Benefits of treatment have not been observed in patients hospitalized due to COVID-19. Monoclonal antibodies may be associated with worse clinical outcomes when given to patients with COVID-19 requiring oxygen ventilation. Individual administration sites may have additional criteria for use of these monoclonal antibody therapies in patients.

For more information about monoclonal antibodies for treatment of COVID-19, contact your primary care provider or the Baxter Regional COVID-19 Infusion Center at (870) 508-3010.

Click here for guidance about monoclonal antibodies from the Arkansas Department of Health.

Related Blogs